創維集團(00751.HK)中期淨利潤3.65億元 同比減少48.9%
格隆匯8月28日丨創維集團(00751.HK)公告,截至2025年6月30日止六個月,集團的整體營業額爲人民幣36,264百萬元,較去年同期的整體營業額人民幣30,153百萬元,上升了人民幣6,111百萬元或20.3%。本期淨利潤爲人民幣365百萬元,較去年同期的人民幣714百萬元減少人民幣349百萬元或48.9%。董事會在充分考慮公司盈利狀況及未來發展資金需求後,決定本期不派發中期股息(截至2024年6月30日止六個月:無)。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.